The diversities of PrP Sc distributions and pathologic changes in various brain regions from a Chinese patient with G114V genetic CJD

Neuropathology

Volumn 32, Issue 1, 2012, Pages 51-59

  Shi, Qi ^a   Zhang, Bao Yun ^a   Gao, Chen ^a   Han, Jun ^a   Wang, Gui Rong ^a   Chen, Cao ^a   Tian, Chan ^a   Dong, Xiao Ping ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Creutzfeldt Jakob disease; G114V; Gliosis; Prion; Spongiform

Indexed keywords

GLYCINE; PRION PROTEIN; VALINE;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN CORTEX; BRAIN REGION; CASE REPORT; CHINESE; CREUTZFELDT JAKOB DISEASE; FEMALE; GENE MUTATION; GLIOSIS; HUMAN; HUMAN TISSUE; NEUROPATHOLOGY; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOTTING, WESTERN; BRAIN; CREUTZFELDT-JAKOB SYNDROME; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUTATION; PRPSC PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84855940097     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2011.01237.x     Document Type: Article

References (27)

1. Collinge J. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 2005; 76: 906-919.
2. Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95: 13363-13383.
3. Pastore M, Chin SS, Bell KL etal. Creutzfeldt-Jakob disease (CJD) with a mutation at codon 148 of prion protein gene: relationship with sporadic CJD. Am J Pathol 2005; 167: 1729-1738.
4. Kovacs GG, Budka H. Molecular pathology of human prion diseases. Int J Mol Sci 2009; 10: 976-999.
5. Kovacs GG, Budka H. Prion diseases: from protein to cell pathology. Am J Pathol 2008; 172: 555-565.
6. Ashok A, Hegde RS. Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog 2009; 5: e1000479.
7. Roeber S, Grasbon-Frodl EM, Windl O etal. Evidence for a pathogenic role of different mutations at codon 188 of PRNP. PLoS ONE 2008; 3: e2147.
8. Ye J, Han J, Shi Q etal. Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series. J Med Case Reports 2008; 2: 331.
9. Rodriguez MM, Peoc'h K, Haïk S etal. A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology 2005; 64: 1455-1457.
10. Almer G, Hainfellner JA, Brucke T etal. Fatal familial insomnia: a new Austrian family. Brain 1999; 122: 5-16.
11. Yin L, Tao Y, Zhao K etal. Proteomic and transcriptomic analysis of rice mature seed-derived callus differentiation. Proteomics 2007; 7: 755-768.
12. Thackray AM, McKenzie AN, Klein MA, Lauder A, Bujdoso R. Accelerated prion disease in the absence of interleukin-10. J Virol 2004; 78: 13697-13707.
13. Abdulmawjood A, Schönenbrücher H, Bülte M. Novel molecular method for detection of bovine- specific central nervous system tissues as bovine spongiform encephalopathy risk material in meat and meat products. J Mol Diagn 2005; 7: 368-374.
14. Deleault NR, Harris BT, Rees JR, Supattapone S. Formation of native prions from minimal components in vitro. Proc Natl Acad Sci USA 2007; 104: 9741-9746.
15. Zhang J, Chen L, Zhang BY etal. Comparison study on clinical and neuropathological characteristics of hamsters inoculated with scrapie strain 263K in different challenging pathways. Biomed Environ Sci 2004; 17: 65-78.
16. Alzualde A, Moreno F, Martínez-Lage P etal. Somatic mosaicism in a case of apparently sporadic Creutzfeldt-Jakob disease carrying a de novo D178N mutation in the PRNP gene. Am J Med Genet B Neuropsychiatr Genet 2010; 153: 1283-1291.
17. Tabernero C, Polo JM, Sevillano MD etal. Fatal familial insomnia: clinical, neuropathological, and genetic description of a Spanish family. Neurol Neurosurg Psychiatry 2000; 68: 774-777.
18. Brahmachari S, Fung YK, Pahan K. Induction of glial fibrillary acidic protein expression in astrocytes by nitric oxide. J Neurosci 2006; 26: 4930-4939.
19. Derkatch IL, Liebman SW. Prion-prion interactions. Prion 2007; 1: 161-169.
20. -/- mice. J Virol 2008; 82: 12464-12471.
21. Kovács GG, Preusser M, Strohschneider M, Budka H. Subcellular localization of disease-associated prion protein in the human brain. Am J Pathol 2005; 166: 287-294.
22. Falsig J, Nilsson KP, Knowles TP, Aguzzi A. Chemical and biophysical insights into the propagation of prion strains. HFSP J 2008; 2: 332-341.
23. Pan T, Wong P, Chang B etal. Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease. J Virol 2005; 79: 934-943.
24. Pan T, Li R, Wong BS, Liu T, Gambetti P, Sy MS. Heterogeneity of normal prion protein in two- dimensional immunoblot: presence of various glycosylated and truncated forms. J Neurochem 2002; 81: 1092-1101.
25. Parchi P, Zou W, Wang W etal. Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 2000; 97: 10168-10172.
26. Ashok A, Hegde RS. Selective processing and metabolism of disease-causing mutant prion proteins. PLoS Pathog 2009; 5: e1000479.
27. Kovács GG, Ertsey C, Majtényi C etal. Inherited prion disease with A117V mutation of the prion protein gene: a novel Hungarian family. J Neurol Neurosurg Psychiatry 2001; 70: 802-805.